Home Privacy Archive Realtime Report

Stock Trading History of Shaaltiel Yoseph

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Shaaltiel Yoseph since year 2005. The trader's CIK number is 1385118. At the time of this reporting, Shaaltiel Yoseph is the Executive VP, R&D of Protalix Biotherapeutics, Inc. (stock ticker symbol PLX).

Stock purchases, sales, and option exercises reported by *Shaaltiel Yoseph* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2007-12-19	PLX	Protalix Biotherapeutics, Inc.	Purchase	4,800	3.40	16,320
2007-12-18	PLX	Protalix Biotherapeutics, Inc.	Purchase	5,100	3.38	17,212
2007-12-17	PLX	Protalix Biotherapeutics, Inc.	Purchase	5,000	3.35	16,750
2007-12-05	PLX	Protalix Biotherapeutics, Inc.	Purchase	15,100	3.12	47,112

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shaaltiel Yoseph (Executive VP, R&D of Protalix Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.